18 West 18th Street
New York, NY 10011
United States
347 767 4220
https://www.mydario.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 241
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Erez Raphael | CEO & Director | 978.76k | N/A | 1973 |
Mr. Richard A. Anderson | Pres | 998.42k | N/A | 1969 |
Mr. Zvi Ben David | CFO, Treasurer & Sec. | 429.05k | N/A | 1961 |
Dov Oppenheim | Co-Founder & Production Chief | N/A | N/A | N/A |
Josh Fischer | Sr. VP of Operations & Compliance | N/A | N/A | N/A |
Claudia Levi | Content & Communications Mang. | N/A | N/A | N/A |
Mary Mooney | VP of Marketing | N/A | N/A | N/A |
Limor Drezner | VP HR & Chief of Staff | N/A | N/A | N/A |
Mr. Olivier R. Jarry | Sr. VP of Strategy & Bus. Devel. | N/A | N/A | 1961 |
Mr. Jean Christophe Muyl | Head of Commercialization North America | N/A | N/A | N/A |
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
DarioHealth Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.